Cyclerion Therapeutics Cash Flow Statement 2017-2025 | CYCN

Net Income/Loss

$-3.057

$-5.263

$-44.078

$-51.647

$-77.802

$-123.008

$-115.252

$-93.922

Total Depreciation And Amortization - Cash Flow

$0.065

$0.472

$2.297

$2.7

$1.528

$1.745

Other Non-Cash Items

$0.262

$-11.381

$6.252

$13.25

$10.607

$20.382

$12.433

$9.494

Total Non-Cash Items

$0.262

$-11.381

$6.317

$13.722

$12.904

$23.082

$13.961

$11.239

Change In Accounts Receivable

$-0.556

$0.096

$0.004

$0.027

$1.346

$-1.474

Change In Inventories

Change In Accounts Payable

$-0.445

$-1.772

$1.142

$0.393

$-1.096

$-0.25

$0.979

$0.392

Change In Assets/Liabilities

$-0.537

$-2.925

$-3.996

$0.988

$-7.842

$-0.565

$2.809

$1.073

Total Change In Assets/Liabilities

$-1.538

$-4.601

$-2.85

$1.408

$-7.592

$-2.289

$3.788

$1.465

Cash Flow From Operating Activities

$-4.333

$-21.245

$-40.611

$-36.517

$-72.49

$-102.215

$-97.503

$-81.218

Net Change In Property, Plant, And Equipment

$1.457

$0.018

$-6.715

$-3.438

$-1.404

Net Change In Intangible Assets

Net Acquisitions/Divestitures

Net Change In Short-term Investments

Net Change In Long-Term Investments

Net Change In Investments - Total

Investing Activities - Other

$10.402

Cash Flow From Investing Activities

$10.402

$1.457

$0.018

$-6.715

$-3.438

$-1.404

Net Long-Term Debt

Net Current Debt

$3.509

Debt Issuance/Retirement Net - Total

$3.509

Net Common Equity Issued/Repurchased

$5.024

$0.029

$0.282

$0.331

$0.51

Net Total Equity Issued/Repurchased

$5.024

$0.029

$0.282

$0.331

$0.51

Total Common And Preferred Stock Dividends Paid

Financial Activities - Other

$30.503

$24.25

$211.061

$100.941

$82.622

Cash Flow From Financial Activities

$5.024

$0.029

$30.785

$28.09

$211.571

$100.941

$82.622

Net Cash Flow

$-4.339

$-5.811

$-40.579

$-4.271

$-44.389

$102.621

Stock-Based Compensation

$0.625

$1.067

$6.252

$9.611

$14.992

$19.631

$12.433

$9.494

Common Stock Dividends Paid